首页> 外文期刊>Chemosphere >Risk-based principles and incompleteness theorems for linear dose-response extrapolation for carcinogenic chemicals
【24h】

Risk-based principles and incompleteness theorems for linear dose-response extrapolation for carcinogenic chemicals

机译:基于风险的原理和不完整定理,用于致癌化学品的线性剂量响应外推

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To conduct better health risk assessments, this study introduced two risk-based principles and a series of line-lognormal-intersection theorems that helped derive the safe ranges of the cancer slope factors (CSFs) for 708 carcinogenic chemicals. The extrapolated linear dose-response relationships presented in this study can ensure safety with respect to both static and dose-based instantaneous risks compared to the lognormal dose-response model. The theorems proved that the maximum static and dose-based hazard risk ratios of a lognormal curve and a linear model are independent of a chemical's toxicity (the effect dose that corresponds to a 50% response, or ED50), where the selected linear extrapolation (m value) and the individual variability (sigma) of the responses to carcinogenic chemicals are two determining factors. The theorems also indicated that individual variability determines the range of m if the acceptable risk ratios were regulated. When s was 1.36 (i.e., the 50th percentile of the individual variability's lognormal distribution), the safe range of m was derived as [11.22, 21.46] (i.e., from ED11.22 to ED21.46); if the 95th percentile of the s lognormal distribution was used, the safe range of m was [1.13, 4.57] (i.e., from ED1.13 to ED4.57). This study also showed that for a relatively homogenous population (i.e., s is relatively small) that has similar characteristics, the linear dose-response extrapolation method might not be completely effective due to the shape shift of the lognormal curve that draws the static risk of the extrapolated linear model away from the lognormal model. (C) 2020 Elsevier Ltd. All rights reserved.
机译:为了进行更好的健康风险评估,本研究引入了两种基于风险的原则和一系列线路逻辑 - 交叉定理,有助于获得708个致癌化学品的癌症斜率因子(CSF)的安全范围。本研究中呈现的外推线性剂量 - 反应关系可以确保与逻辑正常剂量 - 响应模型相比的静态和剂量瞬时风险相比的安全性。本定理证明了伐诺曲线和线性模型的最大静态和基于剂量的危险风险比与化学性毒性(相当于50%反应或ED50)的效果剂量而无关,其中所选的线性外推( M值)和对致癌化学品的反应的单独变异性(Sigma)是两种测定因子。定理还表明,如果调节可接受的风险比,则各个变异性决定了m的范围。当S为1.36时(即,各种变异性的第50百分位数),衍生为[11.22,21.46](即,从ED11.22到ED21.46)的安全范围;如果使用的第95百分位数的第95百分位数,则M为[1.13,4.57](即,从ED1.13到ED4.57)的安全范围。本研究还表明,对于具有相似特性的相对均匀的群体(即,S相对较小),由于绘制静态风险的逻辑正态曲线的形状偏移,线性剂量响应外推方法可能不会完全有效外推线性模型远离逻辑正种模型。 (c)2020 elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号